Biorisk: Doomsday Bug, Resistant to Every Drug, Found in

New Post Public Reply Private Reply Replies (1) Message Board
PoemStone cashclan #17504
287
Biorisk: Doomsday Bug, Resistant to Every Drug, Found in L.A.
1 Feb 2017



Los Angeles County Health authorities issued a national biorisk warning on Tuesday after identifying a patient infected with the 100 percent drug-resistant “mcr-1” bacterial pathogen, apparently acquired through international travel.

last%20resort_thumb.jpg
X-ray crystal structure of the catalytic domain of the MCR-1 protein.

Scientists first reported the emergence of the plasmid-encoded mcr-1 gene, which is completely resistant to all known drugs in a Pennsylvania female patient with a urinary tract infection in November 2015. The discovery set off a worldwide biorisk warning from the World Health Organization, causing bacteriologists to scour their international “collections” of thousands of frozen bacterial isolates in search of any similar gene DNA.

The British Lancet medical journal reported last May that English and Chinese microbiologists had found almost 100 instances of the biorisk gene. With some of the frozen samples going back over five years, researchers indicated that mcr-1 resistance may be more widely distributed than expected.

The L.A. County biorisk warning is the first public disclosure that the mcr-1 gene “has been reported in human specimens from five additional states and in animal specimens from two states.”

California hospital-based health providers are being directed to follow LAC Department of Public Health recommendations regarding infection control, testing, and reporting for patients with suspected and confirmed mcr-1 organisms. All LAC health care facilities also must report any mcr-1 indications within 24 hours of discovery.

The mcr-1 gene is zoonotic, which means it can be transferred from humans to animals or vice versa. After it was first determined in June that seagulls may carry mcr-1, health officials realized that the gene could be subject to airborne transmission; transmission through animal interactions; through handling infected meat; and by drinking animal-contaminated water.

National Geographic reported that mcr-1 drug-resistance is due to mobile genetic elements called plasmids. But rather than just the risk of infection spreading from one person or one animal to another, “plasmids sequencing and subcloning” can move from one bacterial species to another. That has already been documented with E. coli and Klebsiella bacteria in the human stomach swapping their plasmids. That means no one is sure how far and how fast mcr-1 drug resistance will, or has already, spread.


Antibiotic Resistance Gene mcr-1
Not Easily Spread


dt_160526_e_coli_bacteria_800x600.jpg
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bloomberg Tax Celebrates Global Tax Leaders at IFA

Updated Category News Views 50

Spotlight on Global Tax Leadership Here's a twist for you: tax law may not scream excitement, but when international tax changemakers get recognized, even the unflappable have to nod in appreciation. Bloomberg Tax just tossed accolades at five distinguished authors who are mapping the complexities of international tax landscapes. This isn't just about numbers—it's...

Continue Reading
Lincoln Educational Faces Class Action for Stock Drop

Updated Category News Views 68

What's Gripping Lincoln Educational Services? You ever feel like you've stepped into a financial thriller with these education stocks? Well, Lincoln Educational Services (NASDAQ:LINC) is at the heart of one, facing the heat of a class action lawsuit filed by Bleichmar Fonti & Auld LLP. It's all about securities fraud—a dreaded term that no investor wants to hear. The...

Continue Reading
Ad Council Expands Board, Taps Meta Exec as Vice Chair

Updated Category News Views 114

An Unexpected Shuffle at the Ad Council Alright, folks, let's talk shop about the recent shake-up in the nonprofit realm. The Ad Council, which has been around longer than some of the giants controlling today's marketing landscapes, just plumped up its Board of Directors with 23 new heavy-hitters. We're talking about leaders from every nook and cranny of the...

Continue Reading
FIU Cuba Poll: Cuban American Vote Leans GOP

Updated Category News Views 44

Here we got the latest scoop from the 2026 FIU Cuba Poll, and boy, it's a wild ride. Picture this: 76% of Cuban Americans in South Florida aren't fans of Trump’s escalated deportations of Cubans sans criminal records, yet a solid 68% are sticking to their GOP guns come election season. Now, ain't that a head-scratcher? Cuban Americans and the GOP: A Complex Relationship...

Continue Reading
Ferrovial's 2026 Growth: North America Drives Success

Updated Category News Views 6

Solid Gains Across the Board Right off the bat, Ferrovial's 2026 report card screams 'win'. For the first three quarters, they clocked in a hefty 21.8% boost in adjusted EBITDA, and revenue didn't dawdle either, climbing 10.8%—not exactly a stroll in the park to accomplish. North America's No Joke Ferrovial's got a clear hero in their narrative and it's North America....

Continue Reading
Fairfax Crest: A New Chapter in Affordable Housing

Updated Category News Views 52

Setting the Stage: Fairfax Crest's Grand Opening You know what's better than leaving a dusty old car park underutilized? Turning it into homes for folks who really need them. That's exactly what went down in Fairfax County as they cut the ribbon on their latest affordable housing project, Fairfax Crest. We're talking 279 affordable units sprouting up where there once lay...

Continue Reading
Antibiotic Overuse for Sinus Infections Costs Billions

Updated Category News Views 45

Sinus Infections: A Case of Excess Prescriptions You'd think with all the guidelines, doctors would've nailed the sinusitis treatment by now. But nope—antibiotic overuse remains alive and kicking. A fresh dig from Motive Medical Intelligence shows that more than three-quarters of primary care clinicians are quick to hand out antibiotics for acute sinusitis. So here we...

Continue Reading
Personalis Merger Faces Investigation: $16.25 Offers Scrutinized

Updated Category News Views 55

Market Storm or Light Drizzle? When the sharks smell blood or the legal eagles start circling, you know something stinks. BFA Law is sniffing around, and it isn’t just for sport. They’re putting their magnifying glass on this curious $16.25 per share transaction where Tempus AI plans to gobble up Personalis lock, stock, and barrel. For investors holding NASDAQ:PSNL,...

Continue Reading
UP Fintech Faces Class Action Over Alleged Misconduct

Updated Category News Views 36

UP Fintech: A Financial Storm Brews When it rains, it sure pours. Investors are finding themselves stuck in the middle of a squall as UP Fintech Holding Limited's legal troubles unfold. Robbins LLP, a shareholder rights law firm, has filed a class-action lawsuit targeting UP Fintech (NASDAQ:TIGR), and the lawsuit isn't just some casual fling—it digs deep into the...

Continue Reading
San Diego's Iconic Nightlife Venue Revives as The Quin

Updated Category News Views 90

The ghosts of PLUXX's past are getting a new home at The Quin in San Diego. It's happening in the Gaslamp Quarter, where the familiar pulse of a party will hit the scene once again. Instead of peeling walls and the typical downtown club smell, we've got internationally acclaimed DJ Sam Feldt headlining the Halloween bash—Heaven & Hell. The Quin's Next Chapter Begins on...

Continue Reading

Top 5 Most Recently Viewed Articles

Coinbase to Reveal Financial Performance at Upcoming Event

Updated Category News Views 116

Coinbase Financial Results Announcement Coinbase Global, Inc. is gearing up to present its fourth quarter and full year 2024 results. The highly anticipated shareholder letter will be made available on the company’s Investor Relations website. Investors can expect to find comprehensive financial data and insights that reflect the company’s commitment to transparency...

Continue Reading
Kamada Secures $25 Million Supply Agreement for KAMRAB® and VARIZIG®

Updated Category News Views 265

Kamada Secures Major Supply Agreement in Latin America REHOVOT, Israel and HOBOKEN, N.J. – Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global leader in biopharmaceuticals with a renowned portfolio aimed at rare and serious conditions, proudly announces its latest achievement: securing a contract with an influential international organization. Contract Overview This...

Continue Reading
Key Developments on Owlet's Stockholder Derivative Settlement

Updated Category News Views 317

Overview of the Proposed Settlement for Owlet, Inc. Owlet, Inc. (NYSE: OWLT) recently issued a significant notice concerning a proposed settlement in a shareholder derivative lawsuit. This comes as part of a consolidated action that addresses alleged issues raised by shareholders regarding company governance. Details of the Derivative Action The derivative lawsuit,...

Continue Reading
Amcor and Cofigeo Collaborate on Innovative Meal Tray Design

Updated Category News Views 168

Amcor and Cofigeo Collaborate for Sustainable Meal Packaging Amcor, renowned for its commitment to responsible packaging solutions, has recently joined forces with Cofigeo to introduce a groundbreaking multi-compartment tray aimed at improving convenience and sustainability in meal packaging. This collaboration reflects the increasing demand for environmentally friendly...

Continue Reading
MarineMax, Inc. Faces Fraud Investigation: Key Insights for Investors

Updated Category News Views 178

Understanding MarineMax's Recent Challenges MarineMax, Inc. is a prominent name in the recreational marine industry. Recently, the Company has come under scrutiny due to potential securities law violations. This investigation, led by advocates for shareholders, particularly focuses on the allegations that MarineMax misrepresented financial conditions and failed to...

Continue Reading